GHRP-6 — references and citing documents
The full reference list for this monograph, and every Institute document that draws on it.
§10References
Every reference the monograph relies on is listed below in order of first citation across the document. Identifiers are reproduced only where the Institute holds them; where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed one.
This monograph cites 4 sources[1,2,3,4].
Table 9. Bibliographic records for the sources cited by this monograph. Each links to its record page, which lists every Institute document citing it.
| # | Title | Source | Year |
|---|---|---|---|
| 1 | Ipamorelin, the first selective growth hormone secretagogue | European Journal of Endocrinology | 1998 |
| 2 | Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions | Expert Review of Proteomics | 2019 |
| 3 | Stability of protein pharmaceuticals: an update | Pharmaceutical Research | 2010 |
| 4 | Related impurities in peptide medicines | Journal of Pharmaceutical and Biomedical Analysis | 2014 |
§11Related Institute documents
Table 10. Institute documents that draw on, or are drawn on by, this monograph.
| Series | Count | Documents |
|---|---|---|
| Trial abstracts | 6 | GHRP6-PH1-GH · GHRP6-PH1-GH-OLE · GHRP6-PH1-GH-ELDERLY · GHRP6-PH1-GH-BIOMARKER · GHRP6-PH1-GH-ADHERENCE · GHRP6-PH1-GH-QOL |
| Evidence syntheses | 1 | Clinical evidence for growth-hormone secretagogues supplied… |
| Comment periods | 1 | Draft monograph: GHRP-6 |
| Indication assessments | 2 | GH axis · Wound healing |
Numbered reference list
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology 1998;139(5):552–561. doi:10.1530/eje.0.1390552 · PMID 9849822
- Thevis M, Thomas A, Schänzer W. Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. Expert Review of Proteomics 2019;11(6):663–673. doi:10.1586/14789450.2014.965158
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6 · PMID 20143256
- D’Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 2014;101:2–30. doi:10.1016/j.jpba.2014.06.012 · PMID 25044089
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.